Penile squamous cell cancer (PSCC) is the most frequent penile malignant disease. Infections with human papillomaviruses (HPV) are a major etiologic driver of PSCC. However, the molecular details of the underlying carcinogenesis are understudied because of rare clinical specimens and missing cell lines.
Bladder cancer is primarily a disease of older age and little is known about the differences between patients diagnosed with bladder cancer at a younger versus older age. Our objectives were to compare bladder cancer specific survival in patients aged <50 versus those aged 50-70 at time of diagnosis.
The recommended treatment of localized muscle-invasive bladder cancer (MIBC) is cystectomy and neoadjuvant chemotherapy (NAC) for eligible patients. However, the percentage who receive NAC is varying.
Oliver Sartor: Thank you for joining PSMA-PET Academy. I’m Dr. Oliver Sartor, and it’s my pleasure to present the VISION trial. I’m going to talk about some of the design considerations in addition to the data, and maybe a few thoughts that when we move forward. Now, let’s start off by looking at some of […]
Andrea Farolfi: Hello everybody. My name is Andrea Farolfi, and I’m a nuclear medicine physician based in Bologna, Italy. And my field of interest is prostate cancer imaging with PET tracers, such as choline, fluciclovine, and PSMA ligands. I’m going to speak about how to read and report a PSMA PET, including PET terminology, PROMISE/PPP, […]
Ken Herrmann: Hello everybody. It’s my great pleasure to welcome you to the PSMA PET Academy. Together with my great friend, Stefano Fanti, I will introduce you to PSMA-based PET imaging. And I welcome you now officially in the red corner, Professor Stefano Fanti from Bologna. Stefano Fanti: Thank you very much, Ken. It’s a […]
Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different prostate cancer patient groups. In the study “Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse” led by Dr. Alfonso Urbanucci from Oslo University Hospital and Professor Matti Nykter from Tampere […]
(UroToday.com) In a Hot Topic session during the Société Internationale D’Urologie (SIU) 2021 annual meeting focused on the role of artificial intelligence (AI) in urology, Dr. Andrew Hung assessed the role of AI to predict patient outcomes after robotic surgery and for automating skills assessment.
(UroToday.com) In a Hot Topic session of the Société Internationale D’Urologie (SIU) 2021 annual meeting focused on the role of artificial intelligence (AI) in urology, Dr. Jean-Christophe Bernhard discussed the potential of 3-dimensional (3D) models to enhance the quality of robotic-assisted partial nephrectomy.
(UroToday.com) In a Hot Topic session of the Société Internationale D’Urologie (SIU) 2021 annual meeting focused on the role of artificial intelligence (AI) in urology, Dr. Mark Emberton discussed the role of AI in prostate cancer imaging. Building on his plenary session talk regarding advances in prostate cancer imaging over the past decade, Dr. Emberton discussed […]
